Lowry Simon C has filed 8 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 100111 shares of Emergent BioSolutions Inc. ($EBS) on April 29, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 29, 2026 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Common Stock | 100111 | $0.00 | 177,914.0000 | 56,700,000 | 128.67% | 0.18% |
| March 5, 2026 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | F | Common Stock | 10636 | $8.44 | 77,803.0000 | 56,700,000 | 12.03% | 0.02% |
| March 3, 2026 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 147,833.0000 | 56,700,000 | 43.53% | 0.08% |
| Dec. 14, 2025 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | F | Common Stock | 3543 | $11.41 | 88,439.0000 | 56,700,000 | 3.85% | 0.01% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Common Stock | 62500 | $0.00 | 91,982.0000 | 53,000,000 | 211.99% | 0.12% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 102,999.0000 | 53,000,000 | 154.32% | 0.12% |
| Dec. 15, 2024 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Option (Right to buy) | 40499 | $0.00 | 40,499.0000 | 55,600,000 | 9999.99% | 0.07% |
| Dec. 15, 2024 | Emergent BioSolutions Inc. | $EBS | Lowry Simon C | SVP, R&D, CMO | A | Common Stock | 29482 | $0.00 | 29,482.0000 | 55,600,000 | 9999.99% | 0.05% |